ENDRA Life Sciences Inc.
Market Cap
$2.49M
P/E Ratio
0.17
EPS
$19.52
Dividend Yield
0.00%
52-Week Range
$2.90 — $11.96
Volume
4.32K
Avg Volume
109.84K
Beta
-0.11
P/E (TTM)
0.17
Forward P/E
—
PEG Ratio
-0.00
P/S (TTM)
0.00
P/B (TTM)
15.41
P/FCF
—
EV/EBITDA
—
EV/Sales
—
ROE (TTM)
-5.38%
ROA (TTM)
-4.08%
ROIC
—
Gross Margin
0.00%
Operating Margin
0.00%
Net Margin
—
Debt/Equity
3.07
Current Ratio
1.31
EPS Growth (YoY)
—
Revenue Growth (YoY)
—
EPS Growth (3Y)
-0.29%
EPS Growth (5Y)
+0.08%
Sales Growth (3Y)
+0.00%
Sales Growth (5Y)
+0.00%
EPS Est (This Year)
$-4.62
EPS Est (Next Year)
—
Dividend Yield
—
Annual Dividend
—
Payout Ratio
—
Frequency
—
Ex-Dividend Date
—
Cash/Share
$1.04
Institutional %
—
Inst. Net Change
—
Insider Net Shares (90d)
—
Outstanding Shares
752.63K
Float
681.85K
Free Float %
90.59%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Country
US
Exchange
NASDAQ
IPO Date
2017-06-30
Employees
21
CEO
Alexander Y. Tokman
Index Membership
—
Website
https://www.endrainc.com
ENDRA Life Sciences Inc. (NDRA) is a healthcare company in the medical - diagnostics & research industry listed on the NASDAQ. With a market capitalization of $2.49M, a P/E ratio of 0.17, NDRA is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare NDRA against other stocks using dozens of fundamental and technical filters.
ENDRA Life Sciences Inc. (NDRA) has a trailing twelve-month (TTM) P/E ratio of 0.17. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.
No, ENDRA Life Sciences Inc. (NDRA) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.
ENDRA Life Sciences Inc. (NDRA) has a market capitalization of $2.49 million, classifying it as a micro-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.